Jazz Pharmaceuticals plc — Director's Dealing 2021

Mar 1, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2021-02-25

Reporting Person: Cook Jennifer E. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-25	Ordinary Shares	A	2590	$0.0	Acquired	2590	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-25	Non-Qualified Stock Option (right to buy)	$170.74	A	6475	Acquired	2031-02-24	Ordinary Shares (6475)	Direct

Footnotes

F1: These restricted stock units are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in equal annual installments over three years measured from the vesting commencement date of December 1, 2020, with 1/3 vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent two years.

F2: These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest 1/3 on December 1, 2021 and in 24 equal monthly installments thereafter.